Company Filing History:
2 out of 441 
1 out of 26 
1 out of 200 Years Active: 2002-2014
Title: Inventor Masami Ohtsuka: Pioneering mTOR Inhibitory Compounds
Introduction
Masami Ohtsuka, a talented inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals, particularly through her work on imidazopyridin-2-one derivatives. With a total of four patents to her name, she continues to advance research aimed at developing innovative treatments.
Latest Patents
Ohtsuka's most recent patents focus on imidazopyridin-2-one derivatives, showcasing compounds with mTOR inhibitory activity or pharmacologically acceptable salts thereof. The innovative nature of these compounds signifies her dedication to creating effective therapeutic options in the scientific community.
Career Highlights
Throughout her career, Masami Ohtsuka has been associated with prominent companies such as Daiichi Sankyo Company, Limited and Microcide Pharmaceuticals, Inc. Her work has contributed to advancements in drug development and the pharmaceutical industry, demonstrating her exceptional expertise and passion for innovation.
Collaborations
Ohtsuka's collaborations with esteemed colleagues, including Kiyoshi Nakayama and William John Watkins, have further enriched her research and contributed to her achievements as an inventor. These partnerships highlight the collaborative spirit within the scientific community that drives innovation and discovery.
Conclusion
In summary, Masami Ohtsuka stands out as a remarkable inventor whose work continues to impact the pharmaceutical landscape. With her focus on mTOR inhibitory compounds and a strong background in collaboration, she exemplifies the innovative spirit vital for advancing medical research and treatment options.